Search:
Browse
Collection All
bullet
bullet
bullet
bullet
bullet
Listed communities
bullet
bullet
HSE
bullet
bullet
LIS
bullet
bullet
bullet

Irish Health Repository > Hospital Research > Leinster > Adelaide Meath Hospital Tallaght > Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.


Files in This Item:

There are no files associated with this item.



Title: Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.
Authors: Sherlock, Mark
Toogood, Andy A
Steeds, Richard
Citation: Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do. 2009, 95 (7):522-3 Heart
Publisher: Heart (British Cardiac Society)
Journal: Heart (British Cardiac Society)
Issue Date: Apr-2009
URI: http://hdl.handle.net/10147/254115
DOI: 10.1136/hrt.2008.163345
PubMed ID: 19174419
Type: Article
Language: en
MeSH: Dopamine Agonists
Echocardiography
Ergolines
Heart Valve Diseases
Heart Valves
Humans
Hyperprolactinemia
Parkinson Disease
Pergolide
Tricuspid Valve Insufficiency
ISSN: 1468-201X
Appears in Collections: Adelaide Meath Hospital Tallaght

Please use this identifier to cite or link to this item: http://hdl.handle.net/10147/254115
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!



Related articles on PubMed
bullet
bullet
Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
Kenangil G, Ozekmekçi S, Koldas L, Sahin T, Erginöz E
2007 May
bullet
bullet
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Bares M, Rektorová I, Krajcovicová L, Rektor I
2008 Oct
bullet
See all 105 articles

All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.